Recruitment

Eingeschlossene Patienten: 19.622 (Stand 02. Juli 2020)
Amgevita® (Adalimumab)	76
Benepali® (Etanercept)	701
Cimzia® (Certolizumab)	925
Enbrel® (Etanercept)	2864
Erelzi® (Etanercept)	261
Flixabi® (Infliximab)	8
Hulio® (Adalimumab)	36
Humira® (Adalimumab)	2903
Hyrimoz® (Adalimumab)	62
Idacio® (Adalimumab)	2
Imraldi® (Adalimumab)	82
Inflectra™ (Infliximab)	16
Kevzara® (Sarilumab)	129
Kineret® (Anakinra)	89
MabThera® (Rituximab)	1459
Olumiant® (Baricitinib)	399
Orencia® (Abatacept)	835
Remicade® (Infliximab)	762
Remsima® (Infliximab)	10
Rinvoq® (Upadacitinib)	32
Rixathon® (Rituximab)	11
RoActemra® (Tocilizumab)	1330
Simponi® (Golimumab)	446
Xeljanz® (Tofacitinib)	295
Zessly® (Infliximab)	2
Kontrollen	5887